- Alessia Cucci, University of Piemonte Orientale, Italy
Functional and transcriptomic approaches on endothelial cell behavior in response to coagulation factors - Tirsa van Duijl, Sanquin Research, The Netherlands
Molecular footprints of haemostatic disorders - Dario Balestra, University of Ferrara, Italy
Prime Editor nuclease-mediated Translocation and Inversions (PETI) to correct the most common hemophilia A mutation - Yohei Hisada, University of North Carolina, United States
The role of the podoplanin-C-type lectin-like receptor 2 pathway in thrombocytopenia and bleeding in acute promyelocytic leukemia - Maria Francesca Testa, University of Ferrara, Italy
Tailored RNA-therapeutic molecules over recurrent nonsense mutations in hemophilia A
Professor Heimburger Award
Celebrating Science
Professor Dr. Norbert Heimburger, a CSL employee for over three decades, was a pioneer of modern coagulation therapy. Among his many achievements, Prof. Dr. Heimburger developed virus-safe plasma products based on pasteurization, including launching the first effectively virus-inactivated FVIII concentrate in 1981.
In his honor, CSL created the Heimburger Award to recognize the clinical and/or preclinical research of emerging coagulation specialists who are driven to improve the care of patients with bleeding disorders.
Expert Insights: Unlocking Success for the Prof. Heimburger award
Dr. Steven Pipe is one of the members of the Prof. Heimburger Award Scientific Committee. Hear what he has to say about the most compelling applications and details not to be missed in your submission.
Watch video